Warfarin therapy for an octogenarian who has atrial fibrillation.
about
Efficacy of antithrombotic therapy for atrial fibrillation in the oldest oldAntithrombotic drugs in secondary stroke prevention among a community dwelling older populationValue of pacemaker atrial diagnostic data in patients with paroxysmal atrial fibrillation: an opportunity to improve rates of warfarin utilization.Determination of free and total warfarin concentrations in plasma using UPLC MS/MS and its application to a patient samples.Atrial fibrillation in the elderly--an increasing problem that mandates aggressive management.The risks of warfarin use in the elderly.Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation.Vitamin K antagonist use in the elderly: special considerations.Challenges of older patients' knowledge about warfarin therapy.Pacing for the suppression of paroxysmal atrial fibrillation in an 87-year-old patient.Cost of dabigatran for atrial fibrillation.Warfarin therapy for atrial fibrillation in the elderly.Cost-savings analysis of using a portable coagulometer for monitoring homebound elderly patients taking warfarin.Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation.Drotrecogin alfa (activated) treatment of older patients with severe sepsis.Improving the management of warfarin in aged-care facilities utilising innovative technology: a proof-of-concept study.
P2860
Q28196163-910040D8-F8EE-4707-A49E-9E155F44F5E0Q28196830-11FD969B-46AF-40AE-ABB0-5D8057741BF8Q31109552-0D44667F-7BDB-4878-B5FB-24373F5DF2A5Q33837117-A7089CD4-DDD1-4A37-88CE-A199D4CE2817Q34350281-736A3FCB-E510-48A0-8151-8F4770B20A96Q36446904-1FFBE7BE-8FA4-418F-A216-1544965AAB4FQ36956360-4A237756-B8AF-4BBF-B759-1B65BF9E5F8AQ37307689-34BD9C8B-A086-49AE-AF8C-C1EC0D9D8EEFQ37608565-9266C0F0-93F2-4DC7-9B63-9D131701B0D9Q38117337-30D666D2-A60D-4370-B33B-D89E7581E2B7Q42383530-F33EBAC5-E31F-44BA-B247-ACC5991D86F0Q42671198-42BDE455-BA03-4487-B0FF-8FCC023C074AQ43888383-8E198071-B043-4725-B00A-86773A4F5A45Q44578407-BB5C2241-7855-4189-981E-D65AA0CA4074Q44981847-374A7285-9B9D-4923-A294-573B5FE5BCD7Q47765880-C8833596-3D9F-4256-A157-890AF07E44AEQ51818459-4E64D4AC-04C1-4AC9-B515-502B8EEEE54F
P2860
Warfarin therapy for an octogenarian who has atrial fibrillation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Warfarin therapy for an octogenarian who has atrial fibrillation.
@ast
Warfarin therapy for an octogenarian who has atrial fibrillation.
@en
Warfarin therapy for an octogenarian who has atrial fibrillation.
@nl
type
label
Warfarin therapy for an octogenarian who has atrial fibrillation.
@ast
Warfarin therapy for an octogenarian who has atrial fibrillation.
@en
Warfarin therapy for an octogenarian who has atrial fibrillation.
@nl
prefLabel
Warfarin therapy for an octogenarian who has atrial fibrillation.
@ast
Warfarin therapy for an octogenarian who has atrial fibrillation.
@en
Warfarin therapy for an octogenarian who has atrial fibrillation.
@nl
P2093
P1476
Warfarin therapy for an octogenarian who has atrial fibrillation.
@en
P2093
P304
P356
10.7326/0003-4819-134-6-200103200-00011
P407
P577
2001-03-01T00:00:00Z